Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0438398B2 - - Google Patents
[go: Go Back, main page]

JPH0438398B2 - - Google Patents

Info

Publication number
JPH0438398B2
JPH0438398B2 JP1291584A JP1291584A JPH0438398B2 JP H0438398 B2 JPH0438398 B2 JP H0438398B2 JP 1291584 A JP1291584 A JP 1291584A JP 1291584 A JP1291584 A JP 1291584A JP H0438398 B2 JPH0438398 B2 JP H0438398B2
Authority
JP
Japan
Prior art keywords
amino
acid
phenylbutyric acid
phenylbutyric
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP1291584A
Other languages
Japanese (ja)
Other versions
JPS60156394A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP1291584A priority Critical patent/JPS60156394A/en
Publication of JPS60156394A publication Critical patent/JPS60156394A/en
Publication of JPH0438398B2 publication Critical patent/JPH0438398B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明はL−2−アミノ−4−フエニル酪酸の
製法に関する。 本発明の目的化合物L−2−アミノ−4−フエ
ニル酪酸は医薬品原料として重要な物質であり、
又必須アミノ酸L−フエニルアラニンの類似化合
物として生化学分野で種々の用途を有する有用な
物質である。 従来、L−2−アミノ−4−フエニル酪酸の製
法としては、化合的に合成されたDL−2−アミ
ノ−4−フエニル酪酸を光学分割する方法(V.
Du Vigneaud and O.J.Irish.J.Biol.Chem.122349
(1938))等が知られているが、これらの方法は収
率や操作の点で問題があり、工業的に有利な方法
とは言い難い。一方、α−ケト酸を生化学的に直
接α−アミノ酸に変換する代表的な方法として
は、例えば酵素を利用して還元的にアミノ化する
方法或は他のα−アミノ酸のアミノ基を転移させ
る方法等があるが、かかる生化学反応を利用する
場合には、例えばピルピン酸をL−アラニンに変
換させる酵素はオキサル酢酸を殆んどの場合L−
アスパラギン酸へ変化させない等、使用酵素に通
常高い基質特異性が認められる。それ故、生体内
物質の化学変化にはその反応を触媒する酵素が存
在するとしても、生体内物質ではない2−オキソ
−4−フエニル酪酸を処理するに際し、かかる生
化学的手法を利用しうるか否かは、同化合物をL
−2−アミノ−4−フエニル酪酸の転換せしめる
酵素がこれまで発見されていないことからも、従
来全く予測しえなかつた。 かかる状況に鑑み鋭意研究を重ねた結果、本発
明者らはある種の微生物に2−オキソ−4−フエ
ニル酪酸をL−2−アミノ−4−フエニル酪酸へ
転換せしめる酵素の存在することを見出し、本発
明を完成するに至つた。 即ち、本発明によれば、L−2−アミノ−4−
フエニル酪酸はアクロモバクター
(Achromobacter)属、アシネトバクター
(Acinetobacter)属、バチルス(Bacillus)属、
パラコツカス(Paracoccus)属に属し、2−オ
キソ−4−フエニル酪酸からL−2−アミノ−4
−フエニル酪酸を生成せしめる能力を有する微生
物の培養液、該培養液から得た菌体又は菌体処理
物をL−アミノ酸存在下2−オキソ−4−フエニ
ル酪酸に作用させることにより製造することがで
きる。 本発明に使用する微生物としてはアクロモバク
ター属、アシネトバクター属、バチルス属、パラ
コツカス属に属し、2−オキソ−4−フエニル酪
酸からL−2−アミノ−4−フエニル酪酸を生成
せしめる能力を有するものであればいずれも使用
でき、例えばアクロモバクター、リキダム
(Achrombacter liquidum)OUT 8012(微工研
菌寄第12684号)、アシネトバクター、カルコアセ
チカス(Acinetobacter calcoacetics)IFO
12552、バチルス・セレウス(Bacillus cereus)
IFO 3001、パラコツカス・デニトリフイカンス
(Paracoccus denitrificans)IFO 12442等が好適
に挙げられる。 上記微生物の培養は通常の条件下で行うことが
できる。即ち、栄養培地の炭素源としては、上記
微生物の利用可能なものであればいずれも使用で
き、例えば、グルコース、フルクトース、シユク
ロース、マルトース、デキストリン等の糖類、グ
リセロース、ソルビトール等の糖アルコール、フ
マール酸、クエン酸等の有機酸を使用することが
できる。培地への添加量は通常、0.1〜10%程度
とするのが好ましい。窒素源としては、例えば塩
化アンモニウム、硫酸アンモニウム、リン酸アン
モニウム等の無機酸のアンモニウム塩、フマール
酸アンモニウム等の有機酸のアンモニウム塩、肉
エキス、酵母エキス、コーンステープリカー、カ
ゼイン加水分解物等の天然有機窒素源等を使用す
ることができ、このうち有機窒素源は多くの場
合、炭素源として兼用することもできる。窒素源
の添加量は通常、0.1〜10%の範囲が好適である。
また、無機塩類としては例えば、リン酸カリウ
ム、リン酸ナトリウムの如きリン酸アルカリ金
属、塩化カリウム、塩化ナトリウムの如き塩化ア
ルカリ金属、硫酸マグネシウム、硫酸第一鉄の如
き、金属硫酸塩等を好適に使用することができ、
その使用量は通常、0.001〜1%の範囲が好適で
ある。微生物の培養にはPH約5〜8、20〜40℃
で、とりわけPH約6〜7、30〜37℃で好気的条件
下に実施するのが好ましい。 次いで、上記の如くして得られた培養液、該培
養液より得た菌体又は該菌体の処理物を酵素源と
し、これをL−アミノ酸の存在下基質である2−
オキソ−4−フエニル酪酸に作用させることによ
りL−2−アミノ−4−フエニル酪酸を製するこ
とができる。培養液より得た菌体としては例え
ば、遠心分離、過等により分離された菌体が挙
げられ、菌体の処理物としては凍結乾燥菌体、ア
セトン乾燥菌体、洗浄菌体、菌体磨砕物、菌体の
自己消化物、菌体の超音波処理物、菌体抽出物又
はこれらをゲル抱括法や吸着法等のそれ自体公知
の固定化方法により固定化したものが挙げられ
る。固定化したものの具体例としては培養液、菌
体ないし菌体処理物を例えばポリアクリルアミド
ゲル、含硫多糖類ゲル(カラギーナン、フアーセ
レラン等)、コラーゲンゲル、アルギン酸ゲル、
ポリビニルアルコールゲル、寒天ゲル等で固定し
たものが挙げられる。さらに本発明の酵素源たる
菌体処理物としては菌体抽出物から公知の方法を
組合せて精製・採取した酵素をそれ自体も使用す
ることができる。 該反応は培養液の菌体を含む培養液に基質を加
えて実施してもよく、又該培養液より得た菌体又
は該菌体処理物を基質の水溶液に加えて反応させ
てもよい。上記本反応に用いるL−アミノ酸とし
ては例えば、L−アスパラギン酸、L−グルタミ
ン酸又はL−アラニン等があげられ、基質に対し
て当モル以上用いるのが好ましい。 また、反応時間の短縮或いはL−2−アミノ−
4−フエニル酪酸の蓄積量の増加をはかるために
は界面活性剤及び/又は補酵素等の存在下に実施
するのが好ましい。この目的に用いうる界面活性
剤としては例えば、臭化セチルトリメチルアンモ
ニウム、ポリエチレングリコール、p−イソオク
チルフエニルエーテル(ローム アンド ハース
社製 商品名:トリトン X−100)等を用いる
ことができ、その使用量は反応液に対し0.0001〜
0.1%程度とするのが好ましい。又、上記目的に
用いうる補酵素としては例えば、ピリドキサール
リン酸を挙げることができ、概ね反応液に対して
0.001〜1mM程度の濃度で用いるのが好ましい。 このようにして反応液中に蓄積したL−2−ア
ミノ−4−フエニル酪酸はそれ自体は水に殆ど不
溶であり、過又は遠心分離等通常の手段を用い
て容易に反応液から分離・採取することができ
る。また、L−2−アミノ−4−フエニル酪酸は
酸又はアルカリ性塩にすると水に可溶性となるた
め、反応液に酸又はアルカリを加え過して不純
物を除き、液を中和してL−2−アミノ−4−
フエニル酪酸結晶を析出させた後、過、遠心分
離等の常法で反応液から分離・採取することもで
きる。 以下、実施例を挙げて本発明を具体例に説明す
る。 尚、実施例中の2−オキソ−4−フエニル酪酸
及びL−2−アミノ−4−フエニル酪酸の定量は
液体クロマトグラフイー法により行ない、L−2
−アミノ−4−フエニル酪酸の確認は取得結晶の
元素分析値並びに予め合成したN−アセチル−
DL−2−アミノ−4−フエニル酪酸に市販のア
ミノアシラーゼを作用させて製したL−2−アミ
ノ−4−フエニル酪酸と比旋光度、NMR及びIR
スペクトルを比較する等して行なつた。本明細書
中”%”はいずれも”重量/容量(g/ml)”を
意味するものとする。 実施例 1 (1) グルコース1%、カゼイン加水分解物1%、
酵母エキス1%、リン酸水素2アンモニウム
0.2%、リン酸2水素カリウム0.1%、硫酸マグ
ネシウム0.05%、硫酸第1鉄0.001%、塩化カ
ルシウム0.01%及びカラリン102(三洋化成工業
株式会社製商品名)0.003%から成る培地50ml
(PH7.0)を120℃で10分間滅菌した。該培地に
パラコツカス・デニトリフイカンス
(Paracoccus denitrificans)IFO 12442を1白
金耳接種後、30℃で18時間振盪培養した。培養
後、培養液を遠心分離して集菌した後、菌体を
凍結乾燥することにより、凍結乾燥菌体0.5g
を調製した。 (2) 2−オキソ−4−フエニル酪酸4g、L−ア
スパラギン酸3.2g及びピリドキサールリン酸
0.003gを水に溶解し、アンモニア水でPH8.5と
した後、水を加えて全体を100mlとした基質溶
液に上記(1)で調製した凍結乾燥菌体1gを加え
30℃で2日間反応させた。該反応液に塩酸を加
えて生成物を溶解させ、活性炭2gを加えて吸
引過した。液を水酸化ナトリウムで中和
し、析出した結晶を取することによりL−2
−アミノ−4−フエニル酪酸3.1gを得た。収
率78% 融点:286〜288℃(分解) 〔α〕22 D+47℃(C=1、1N−HCl) 実施例2〜4 実施例1−(1)と同様にして下記第1表に示す微
生物を培養し、その培養液100mlから遠心分離に
よつて集菌した菌体を基質溶液(2−オキソ−4
−フエニル酪酸4g、L−アスパラギン酸3.2g、
臭化セチルトリメチルアンモニウム10mgを100ml
の水に溶解し、水酸化ナトリウム水溶液でPH8.5
として調製)に懸濁した。この懸濁液を30℃で2
日間反応させることにより、L−2−アミノ−4
−フエニル酪酸が得られた。結果は下記表に示す
通りである。
The present invention relates to a method for producing L-2-amino-4-phenylbutyric acid. The target compound of the present invention, L-2-amino-4-phenylbutyric acid, is an important substance as a pharmaceutical raw material,
It is also a useful substance that has various uses in the biochemical field as a similar compound to the essential amino acid L-phenylalanine. Conventionally, L-2-amino-4-phenylbutyric acid has been produced by optically resolving chemically synthesized DL-2-amino-4-phenylbutyric acid (V.
Du Vigneaud and OJIrish.J.Biol.Chem. 122 349
(1938)), but these methods have problems in terms of yield and operation, and cannot be said to be industrially advantageous. On the other hand, typical methods for directly biochemically converting α-keto acids into α-amino acids include reductive amination using enzymes or transfer of the amino group of other α-amino acids. However, when such a biochemical reaction is used, for example, the enzyme that converts pyrupic acid to L-alanine converts oxalacetic acid into L-alanine in most cases.
The enzyme used usually has high substrate specificity, such as not converting it to aspartic acid. Therefore, even though there are enzymes that catalyze chemical changes in biological substances, it is not possible to use such biochemical methods to treat 2-oxo-4-phenylbutyric acid, which is not a biological substance. Whether or not the same compound is L
This was completely unpredictable since no enzyme that converts -2-amino-4-phenylbutyric acid has been discovered so far. As a result of extensive research in view of this situation, the present inventors discovered that certain microorganisms contain an enzyme that converts 2-oxo-4-phenylbutyric acid to L-2-amino-4-phenylbutyric acid. , we have completed the present invention. That is, according to the present invention, L-2-amino-4-
Phenylbutyric acid is derived from the genus Achromobacter, genus Acinetobacter, genus Bacillus,
Belongs to the genus Paracoccus, and produces L-2-amino-4 from 2-oxo-4-phenylbutyric acid.
- It can be produced by allowing a culture solution of a microorganism capable of producing phenylbutyric acid, bacterial cells obtained from the culture solution, or a processed product of the bacterial cells to act on 2-oxo-4-phenylbutyric acid in the presence of L-amino acids. can. The microorganisms used in the present invention belong to the genus Achromobacter, Acinetobacter, Bacillus, and Paracoccus, and have the ability to produce L-2-amino-4-phenylbutyric acid from 2-oxo-4-phenylbutyric acid. Any of them can be used, such as Achromobacter, Achromobacter liquidum OUT 8012 (Feikoken Bibori No. 12684), Acinetobacter, Acinetobacter calcoacetics IFO
12552, Bacillus cereus
Preferred examples include IFO 3001 and Paracoccus denitrificans IFO 12442. The above microorganisms can be cultured under normal conditions. That is, as a carbon source for the nutrient medium, any carbon source that can be used by the above-mentioned microorganisms can be used, such as sugars such as glucose, fructose, sucrose, maltose, and dextrin, sugar alcohols such as glycerose and sorbitol, and fumaric acid. Organic acids such as , citric acid and the like can be used. The amount added to the medium is usually preferably about 0.1 to 10%. Examples of nitrogen sources include ammonium salts of inorganic acids such as ammonium chloride, ammonium sulfate, and ammonium phosphate, ammonium salts of organic acids such as ammonium fumarate, and natural sources such as meat extract, yeast extract, corn staple liquor, and casein hydrolyzate. An organic nitrogen source can be used, and in many cases, the organic nitrogen source can also be used as a carbon source. The amount of nitrogen source added is usually preferably in the range of 0.1 to 10%.
Preferred examples of inorganic salts include alkali metal phosphates such as potassium phosphate and sodium phosphate, alkali metal chlorides such as potassium chloride and sodium chloride, metal sulfates such as magnesium sulfate, and ferrous sulfate. can be used,
The amount used is usually preferably in the range of 0.001 to 1%. For culturing microorganisms, pH is approximately 5-8, 20-40℃
In particular, it is preferably carried out under aerobic conditions at a pH of about 6-7 and 30-37°C. Next, the culture fluid obtained as described above, the bacterial cells obtained from the culture fluid, or the processed product of the bacterial cells are used as an enzyme source, and this is used as an enzyme source in the presence of L-amino acids.
L-2-amino-4-phenylbutyric acid can be produced by acting on oxo-4-phenylbutyric acid. Examples of bacterial cells obtained from a culture solution include bacterial cells separated by centrifugation, filtration, etc., and processed bacterial cells include freeze-dried bacterial cells, acetone-dried bacterial cells, washed bacterial cells, and bacterial cell polishing. Examples include crushed materials, autolysed bacterial cells, ultrasonicated bacterial cells, bacterial cell extracts, and those obtained by immobilizing these by a known immobilization method such as a gel entrapment method or an adsorption method. Specific examples of immobilized materials include culture solutions, bacterial cells, or treated bacterial cells, such as polyacrylamide gels, sulfur-containing polysaccharide gels (carrageenan, fur-cerelan, etc.), collagen gels, alginate gels,
Examples include those fixed with polyvinyl alcohol gel, agar gel, etc. Furthermore, as the enzyme source of the present invention, an enzyme purified and collected from a bacterial cell extract by a combination of known methods can also be used. The reaction may be carried out by adding a substrate to a culture solution containing microbial cells, or the microbial cells obtained from the culture solution or the processed product of the microbial cells may be added to an aqueous solution of the substrate and the reaction may be carried out. . Examples of the L-amino acid used in the above-mentioned main reaction include L-aspartic acid, L-glutamic acid, and L-alanine, and it is preferable to use at least an equivalent molar amount to the substrate. In addition, shortening of reaction time or L-2-amino-
In order to increase the amount of 4-phenylbutyric acid accumulated, it is preferable to carry out the reaction in the presence of a surfactant and/or a coenzyme. Examples of surfactants that can be used for this purpose include cetyltrimethylammonium bromide, polyethylene glycol, and p-isooctyl phenyl ether (trade name: Triton X-100, manufactured by Rohm and Haas). The amount used is 0.0001~ relative to the reaction solution.
It is preferably about 0.1%. In addition, as a coenzyme that can be used for the above purpose, for example, pyridoxal phosphate can be mentioned, and it is generally
It is preferable to use it at a concentration of about 0.001 to 1 mM. The L-2-amino-4-phenylbutyric acid accumulated in the reaction solution in this way is almost insoluble in water and can be easily separated and collected from the reaction solution using conventional means such as filtration or centrifugation. can do. In addition, since L-2-amino-4-phenylbutyric acid becomes soluble in water when made into an acid or alkaline salt, an acid or alkali is added to the reaction solution to remove impurities and the solution is neutralized. -amino-4-
After phenylbutyric acid crystals are precipitated, they can be separated and collected from the reaction solution by conventional methods such as filtration or centrifugation. Hereinafter, the present invention will be specifically explained with reference to Examples. In addition, the quantitative determination of 2-oxo-4-phenylbutyric acid and L-2-amino-4-phenylbutyric acid in the examples was carried out by liquid chromatography.
-Amino-4-phenylbutyric acid was confirmed using the elemental analysis values of the obtained crystals and the pre-synthesized N-acetyl-
L-2-amino-4-phenylbutyric acid produced by reacting commercially available aminoacylase with DL-2-amino-4-phenylbutyric acid and specific rotation, NMR and IR
This was done by comparing spectra. In this specification, "%" means "weight/volume (g/ml)". Example 1 (1) 1% glucose, 1% casein hydrolyzate,
Yeast extract 1%, diammonium hydrogen phosphate
0.2%, potassium dihydrogen phosphate 0.1%, magnesium sulfate 0.05%, ferrous sulfate 0.001%, calcium chloride 0.01%, and Calalin 102 (trade name manufactured by Sanyo Chemical Industries, Ltd.) 0.003%.
(PH7.0) was sterilized at 120°C for 10 minutes. One platinum loop of Paracoccus denitrificans IFO 12442 was inoculated into the medium, and cultured with shaking at 30°C for 18 hours. After culturing, the culture solution is centrifuged to collect bacteria, and the cells are freeze-dried to obtain 0.5 g of freeze-dried cells.
was prepared. (2) 4g of 2-oxo-4-phenylbutyric acid, 3.2g of L-aspartic acid and pyridoxal phosphate
Dissolve 0.003g in water, adjust the pH to 8.5 with aqueous ammonia, add water to make a total of 100ml, and add 1g of the freeze-dried bacterial cells prepared in (1) above to the substrate solution.
The reaction was carried out at 30°C for 2 days. Hydrochloric acid was added to the reaction solution to dissolve the product, 2 g of activated carbon was added, and the mixture was filtered under suction. By neutralizing the liquid with sodium hydroxide and collecting the precipitated crystals, L-2
3.1 g of -amino-4-phenylbutyric acid was obtained. Yield 78% Melting point: 286-288°C (decomposition) [α] 22 D +47°C (C = 1, 1N-HCl) Examples 2 to 4 In the same manner as Example 1-(1), the results are shown in Table 1 below. The microorganisms shown were cultured, and the bacterial cells collected from 100 ml of the culture solution by centrifugation were added to a substrate solution (2-oxo-4
-4 g of phenylbutyric acid, 3.2 g of L-aspartic acid,
Cetyltrimethylammonium bromide 10mg to 100ml
Dissolved in water, pH8.5 with sodium hydroxide aqueous solution
(prepared as ). This suspension was heated at 30℃ for 2 hours.
By reacting for several days, L-2-amino-4
-Phenylbutyric acid was obtained. The results are shown in the table below.

【表】 実施例 5 グルコース100g、カゼイン加水分解物150g、
コーンステープリカー50g、酵母エキス100g、
リン酸水素2アンモニウム20g、リン酸水素2カ
リウム10g、硫酸マグネシウム5g、硫酸第1鉄
0.1g、塩化カシンウム1g、カラリン102(三洋
化成工業株式会社製商品名)0.3g及び水10か
ら成る培地(PH7.0)を丸菱株式会社製MSJ−u
型20容ジヤーフアメンターに仕込み120℃で10
分間滅菌した。該培地に30℃で18時間振盪下フラ
スコ培養したパラコツカス・デニトリフイカンス
(Paracoccus denitrificans)IFO 12442の菌体液
100mlを接種し、1/2vwm、400rpm、30℃で20
時間培養した。次いで、該培養液に2−オキソ−
4−フエニル酪酸400g、L−アスパラギン酸320
g、臭化セチルトリメチルアンモニウム1gを加
え、アンモニア水でPH8.5に調整した後、37℃で
2日間反応させた。2日後培養液中には、2−オ
キソ−4−フエニル酪酸が認められず、L−2−
アミノ−4−フエニル酪酸360gが生成蓄積して
いた。遠心過機で該反応液から菌体及び培養液
等の不純物を除き、残存結晶を純水に懸濁して洗
浄することにより、L−2−アミノ−4−フエニ
ル酪酸の結晶320gを得た。収率79.5%。
[Table] Example 5 100g of glucose, 150g of casein hydrolyzate,
50g corn staple liquor, 100g yeast extract,
Diammonium hydrogen phosphate 20g, dipotassium hydrogenphosphate 10g, magnesium sulfate 5g, ferrous sulfate
A medium (PH7.0) consisting of 0.1 g, 1 g of calcium chloride, 0.3 g of Calalin 102 (trade name manufactured by Sanyo Chemical Industries, Ltd.) and 10 g of water was added to MSJ-u manufactured by Marubishi Corporation.
Pour into a 20 volume jar fermentor and heat at 120℃ for 10 minutes.
Sterilized for minutes. Cell fluid of Paracoccus denitrificans IFO 12442 cultured in a flask under shaking at 30°C for 18 hours in this medium.
Inoculate 100ml and inoculate at 1/2vwm, 400rpm, 30℃ for 20
Cultured for hours. Next, 2-oxo-
4-phenylbutyric acid 400g, L-aspartic acid 320g
After adding 1 g of cetyltrimethylammonium bromide and adjusting the pH to 8.5 with aqueous ammonia, the mixture was reacted at 37°C for 2 days. 2-oxo-4-phenylbutyric acid was not observed in the culture solution after 2 days, and L-2-
360 g of amino-4-phenylbutyric acid was produced and accumulated. Impurities such as bacterial cells and culture fluid were removed from the reaction solution using a centrifuge, and the remaining crystals were suspended in pure water and washed to obtain 320 g of crystals of L-2-amino-4-phenylbutyric acid. Yield 79.5%.

Claims (1)

【特許請求の範囲】 1 2−オキソ−4−フエニル酪酸からL−2−
アミノ−4−フエニル酪酸を生成せしめる能力を
有するアクロモバクター属、アシネトバクター
属、バチルス属又はパラコツカス属微生物の培養
液、該培養液から得た菌体又は該菌体の処理物を
L−アミノ酸の存在下2−オキソ−4−フエニル
酪酸に作用させ、生成したL−2−アミノ−4−
フエニル酪酸を採取することを特徴とするL−2
−アミノ−4−フエニル酪酸の製法。 2 L−アミノ酸がL−アスパラギン酸、L−グ
ルタミン酸又はL−アラニンである特許請求の範
囲第1項記載の製法。
[Claims] 1 2-oxo-4-phenylbutyric acid to L-2-
A culture solution of a microorganism of the genus Achromobacter, Acinetobacter, Bacillus or Paracoccus that has the ability to produce amino-4-phenylbutyric acid, cells obtained from the culture solution, or a processed product of the cells are used to produce L-amino acids. 2-oxo-4-phenylbutyric acid in the presence of L-2-amino-4-
L-2 characterized by collecting phenylbutyric acid
-Production method of amino-4-phenylbutyric acid. 2. The production method according to claim 1, wherein the L-amino acid is L-aspartic acid, L-glutamic acid, or L-alanine.
JP1291584A 1984-01-26 1984-01-26 Preparation of l-2-amino-4-phenylbutyric acid Granted JPS60156394A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1291584A JPS60156394A (en) 1984-01-26 1984-01-26 Preparation of l-2-amino-4-phenylbutyric acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1291584A JPS60156394A (en) 1984-01-26 1984-01-26 Preparation of l-2-amino-4-phenylbutyric acid

Publications (2)

Publication Number Publication Date
JPS60156394A JPS60156394A (en) 1985-08-16
JPH0438398B2 true JPH0438398B2 (en) 1992-06-24

Family

ID=11818638

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1291584A Granted JPS60156394A (en) 1984-01-26 1984-01-26 Preparation of l-2-amino-4-phenylbutyric acid

Country Status (1)

Country Link
JP (1) JPS60156394A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0787778B2 (en) * 1987-12-10 1995-09-27 田辺製薬株式会社 Novel microorganism and method for producing L-amino acid using the same
US5665508A (en) * 1991-07-23 1997-09-09 Minolta Camera Kabushiki Kaisha Electrophotography carrier having domains dispersed in a matrix resin with a dispersion assistant interposed

Also Published As

Publication number Publication date
JPS60156394A (en) 1985-08-16

Similar Documents

Publication Publication Date Title
EP0249188B1 (en) Process for the production of L-2-amino-4-(hydroxymethyl-phosphinyl)-butyric acid
US4080259A (en) Process of preparing L and D α-amino acids by enzyme treatment of DL-α-amino acid amide
JPH0693839B2 (en) Method for producing L-2-amino-4- (hydroxymethylphosphinyl) butyric acid
JPS62289A (en) Enzymatic production of l-alpha-amino acid from alpha-ketoic acid
JP2950896B2 (en) Method for producing D-α-phenylglycine
JPH0411194B2 (en)
JPS6129953B2 (en)
JPH0928390A (en) Microbiological production method of glycolic acid
JPH0438398B2 (en)
JPH01320991A (en) Production of d-homophenylalanines
EP0187525B1 (en) Process for producing l-serine
JPH0148758B2 (en)
JPH03277292A (en) Production of optically active 2-hydroxycarboxylic acid
JP2924679B2 (en) Production method of D-lysine
WO1996031616A1 (en) Process for producing l-2-aminoadipic acid
JPH1042886A (en) Method for producing β-alanine by microorganism
JP2674078B2 (en) Process for producing D-α-amino acid
JP2899071B2 (en) Method for producing L-α-alanine
JPH03112490A (en) Production of l-homophenylalanine
JP2674076B2 (en) Method for producing D-α-amino acid
JPS6225353B2 (en)
JPH0630572B2 (en) L-phenylalanine dehydrogenase
JPH03112491A (en) Production of l-homophenylalanine
JPH07250694A (en) Production of l-2-amino-4-(hydroxymethylphosphinyl)-butyric acid
JPH0533039B2 (en)

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term